-
Fortress Biotech Prices Series A Preferred Stock Offering
Post on 2/13/20
-
Tonix Pharmaceuticals Closes $7.5M Public Offering
Post on 2/13/20
-
Agile Therapeutics Enters into up to $35M Loan Facility with Perceptive Advisors
Post on 2/13/20
-
Seelos Therapeutics Prices $5M Public Offering of Common Stock
Post on 2/13/20
-
High Focus Centers Opens New Outpatient Treatment Facility In Norwalk, CT
Post on 2/13/20
-
All-Care Physical Therapy Partners with the Ivy Rehab Network
Post on 2/13/20
-
Acorda Therapeutics Provides Business Update
Post on 2/13/20
-
Merck's Keytruda Helps Treat an Aggressive Form of Breast Cancer
Post on 2/13/20
-
Cleveland Physical Therapy Associates Joins the Ivy Rehab Network
Post on 2/12/20
-
BD, Babson Diagnostics Announce Strategic Partnership Agreement
Post on 2/12/20
-
Dr. Reddy’s Laboratories to Acquire Select Business Divisions of Wockhardt in India
Post on 2/12/20
-
Professional Physical Therapy Partners with Physitrack over Patient Engagement Technology
Post on 2/12/20
-
Why Teladoc Health Stock Popped 21.5% in January
Post on 2/12/20
-
Johnson & Johnson Is Racing Against Time to Develop the First Coronavirus Vaccine
Post on 2/12/20
-
Johnson & Johnson Announces Partnership With U.S. government to Accelerate Coronavirus Vaccine Development
Post on 2/12/20
-
Volastra Therapeutics Launches with $12 Million in Seed Financing
Post on 2/11/20
-
Bristol-Myers Squibb Stock Is Too Cheap to Ignore
Post on 2/10/20
-
Johnson & Johnson Submits FDA Application for Multiple Myeloma Drug
Post on 2/10/20
-
OncoSec Announces Closing of the CGP/Sirtex Transaction
Post on 2/10/20
-
Better Choice Company Announces Intention to Form an Animal Health & Wellness Joint Venture with cbdMD
Post on 2/10/20
-
M Science Receives SFC Approval to Advise on Securities in Hong Kong and Establishes First Asia-Pacific Office
Post on 2/10/20
-
ADMA Biologics Prices Upsized $82.3M Public Offering of Common Stock
Post on 2/9/20
-
ADMA Biologics Announces Proposed $75 Million Public Offering of Common Stock
Post on 2/9/20
-
Tonix Pharmaceuticals Prices $7.5 million Public Offering
Post on 2/9/20
-
Bellerophon Announces 1-for-15 Reverse Stock Split
Post on 2/9/20
New York
